Endeavor

How One Moffitt Team Is Using AI To Help Decode Cancer Care

ECHO is designed to help researchers connect complex cancer data faster while keeping human expertise at the center of every decision

Targeted Therapy Could Help Patients With Rare Bone Marrow Cancer

Phase 2 study presented at ASCO finds symptom and spleen improvements for patients with limited options

New Drug Combination Improves Survival in Aggressive Bladder Cancer

Findings could shift how muscle-invasive bladder cancer is treated

Structured Exercise Improves Survival and Quality of Life in Colon Cancer Patients, Study Finds

Three-year international trial shows meaningful gains in disease-free and overall survival following post-treatment physical activity

Study Shows Combined Therapy Helps Advanced Colorectal Cancer Patients Live Longer

Patients receiving trial medications had a 65.7% partial or complete response to treatment

Is Immunotherapy Before and After Surgery a Better Strategy for Certain Cancers?

Several studies from the ASCO Annual Meeting suggest earlier use of immunotherapy improves survival for colon, head and neck and stomach cancers

Drug Combination Proves More Effective for Patients with Advanced Stage 3 Melanoma

Results of a recent NCI-sponsored clinical trial point to lower disease progression and recurrence rates in patients with melanoma

Can Triplet Therapy Help Treat Symptomatic Melanoma Brain Metastases?

Targeted therapy combined with immunotherapy gave patients longer progression-free survival and higher response rates, study says

New Drug Duo Significantly Slows Progression of Aggressive Breast Cancer

Phase 3 trial shows sacituzumab govitecan and pembrolizumab outperform standard treatment in triple-negative breast cancer